Qianqian Ye

643 total citations
30 papers, 410 citations indexed

About

Qianqian Ye is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Qianqian Ye has authored 30 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Qianqian Ye's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Qianqian Ye is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Qianqian Ye collaborates with scholars based in China, United States and Netherlands. Qianqian Ye's co-authors include Hua-Tao Wu, Manli Zhang, Jing Liu, Jiaxin Shen, Guanwu Li, Huiting Zhong, Wen-Jia Chen, Zhong-Yi Lu, Wenguang Zhou and Kai Liu and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Physical Review B.

In The Last Decade

Qianqian Ye

28 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qianqian Ye China 12 184 106 59 48 39 30 410
Jijia Li China 13 245 1.3× 58 0.5× 54 0.9× 35 0.7× 29 0.7× 33 467
Tian Qin China 13 116 0.6× 70 0.7× 64 1.1× 104 2.2× 14 0.4× 38 676
Paolo Oliva Italy 8 156 0.8× 49 0.5× 93 1.6× 13 0.3× 36 0.9× 11 409
Qing You China 10 194 1.1× 73 0.7× 43 0.7× 41 0.9× 3 0.1× 37 412
Yu−Syuan Chen Taiwan 11 364 2.0× 185 1.7× 228 3.9× 124 2.6× 109 2.8× 16 792
Miao Su China 12 187 1.0× 76 0.7× 106 1.8× 68 1.4× 5 0.1× 44 590
Minglu Liu China 13 94 0.5× 23 0.2× 57 1.0× 15 0.3× 55 1.4× 31 397

Countries citing papers authored by Qianqian Ye

Since Specialization
Citations

This map shows the geographic impact of Qianqian Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianqian Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianqian Ye more than expected).

Fields of papers citing papers by Qianqian Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianqian Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianqian Ye. The network helps show where Qianqian Ye may publish in the future.

Co-authorship network of co-authors of Qianqian Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Qianqian Ye. A scholar is included among the top collaborators of Qianqian Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianqian Ye. Qianqian Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Qianqian, Fangyi Xiao, J.S.T. Huang, et al.. (2025). Individualized diagnosis of Parkinson’s disease based on multivariate magnetic resonance imaging radiomics and clinical indexes. Frontiers in Aging Neuroscience. 17. 1504733–1504733. 3 indexed citations
2.
Miao, Harry, Jian Gao, Lian See Tan, et al.. (2025). Antibody‐Programmable Bimetallic Nanozymes for Transcriptional Blockade Therapy in HER2/ER‐Positive Breast Cancer. Advanced Functional Materials. 35(48).
3.
Lu, Yao, et al.. (2024). Detection of elevated levels of PINK1 in plasma from patients with idiopathic Parkinson’s disease. Frontiers in Aging Neuroscience. 16. 1369014–1369014. 3 indexed citations
4.
Li, Meifang, Shaozhong Li, De Zeng, et al.. (2023). Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells. Cell Death Discovery. 9(1). 204–204. 11 indexed citations
5.
Chen, Zhi, et al.. (2023). Examining the impact of early enteral nutritional support on postoperative recovery in patients undergoing surgical treatment for gastrointestinal neoplasms. World Journal of Gastrointestinal Surgery. 15(10). 2222–2233. 7 indexed citations
6.
Sun, Haoran, Jun Zhang, Qianqian Ye, et al.. (2023). LPGAT1 controls MEGDEL syndrome by coupling phosphatidylglycerol remodeling with mitochondrial transport. Cell Reports. 42(11). 113214–113214. 9 indexed citations
8.
Zhang, Yu, et al.. (2022). Resistance characterization of the natural population and resistance mechanism to pyraclostrobin in Lasiodiplodia theobromae. Pesticide Biochemistry and Physiology. 188. 105232–105232. 12 indexed citations
9.
Feng, Liang, Xi Xiong, Qianqian Ye, et al.. (2022). Plasma-derived phosphoglycerate mutase 5 as a biomarker for Parkinson’s disease. Frontiers in Aging Neuroscience. 14. 1022274–1022274. 2 indexed citations
11.
Ye, Qianqian. (2021). Intelligent Inspection System of Power Equipment Based on Photoelectric Sensor/AR Technology. Journal of Nanoelectronics and Optoelectronics. 16(10). 1645–1656. 3 indexed citations
12.
Wu, Hua-Tao, Wen-Jia Chen, Chunlan Li, et al.. (2021). Diverse expression patterns of mucin 2 in colorectal cancer indicates its mechanism related to the intestinal mucosal barrier. World Journal of Gastroenterology. 27(25). 3888–3900. 4 indexed citations
13.
Chen, Wentian, Hua-Tao Wu, Jiaxin Shen, et al.. (2021). Long non-coding RNAs engender drug resistance to different subtypes of treatments of breast cancers and may provide a "next generation" therapy option.. PubMed. 29(156). 27–39. 1 indexed citations
14.
Zhang, Manli, Hua-Tao Wu, Wen-Jia Chen, et al.. (2020). Involvement of glutathione peroxidases in the occurrence and development of breast cancers. Journal of Translational Medicine. 18(1). 247–247. 33 indexed citations
15.
Wu, Yang, Hua-Tao Wu, Wen-Jia Chen, et al.. (2020). MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas. Cell Death and Disease. 11(10). 912–912. 19 indexed citations
16.
Xu, Ya, Jing Liu, Wen-Jia Chen, et al.. (2020). Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate. Frontiers in Cell and Developmental Biology. 8. 561703–561703. 11 indexed citations
17.
Liu, Jing, Wen-Jia Chen, Qianqian Ye, et al.. (2020). The Diverse Roles of the Mucin Gene Cluster Located on Chromosome 11p15.5 in Colorectal Cancer. Frontiers in Cell and Developmental Biology. 8. 514–514. 10 indexed citations
18.
Wu, Hua-Tao, Huiting Zhong, Guanwu Li, et al.. (2020). Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer. Journal of Translational Medicine. 18(1). 51–51. 110 indexed citations
19.
Wu, Hua-Tao, Wentian Chen, Guanwu Li, et al.. (2020). Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction. Frontiers in Genetics. 10. 1328–1328. 26 indexed citations
20.
Chao, Qianwen, Zhigang Deng, Jiaping Ren, Qianqian Ye, & Xiaogang Jin. (2017). Realistic Data-Driven Traffic Flow Animation Using Texture Synthesis. IEEE Transactions on Visualization and Computer Graphics. 24(2). 1167–1178. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026